Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
Starting in January, seniors enrolled in Medicare will see a significant reduction in their out-of-pocket costs for ...